SRC as a novel therapeutic target fot the treatment of triple negative breast cancer (TNBC)

被引：0
|
作者：
Walsh, S. [1 ]
Tryfonopoulos, D. [2 ,3 ]
Quinn, C. [4 ]
Flanagan, L. [4 ]
Pierce, A. [1 ]
McDermott, E. W. [1 ]
Evoy, D. [1 ]
O'Donovan, N. [2 ]
Crown, J. [2 ,3 ]
Duffy, M. J. [1 ,4 ]
机构：
[1] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland
[2] Dublin City Univ, NICB, Dublin 9, Ireland
[3] St Vincents Univ Hosp, Dept Med Oncol, Dublin 4, Ireland
[4] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2011年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [1] WNT PATHWAY AS THERAPEUTIC TARGET OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Huelsewig, C.
    Goette, M.
    Ruckert, C.
    Buchweitz, O.
    Kiesel, L.
    Pusztai, L.
    Liedtke, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 39 - 39
  • [2] Erk5 as a therapeutic target in triple negative breast cancer (TNBC)
    Miranda, Mariska Sauzine
    Al Ejeh, Fares
    Shi, Wei
    Simpson, Peter
    Lakhani, Sunil
    Khanna, Kum Kum
    CANCER RESEARCH, 2015, 75
  • [3] Src: a potential target for the treatment of triple-negative breast cancer
    Tryfonopoulos, D.
    Walsh, S.
    Collins, D. M.
    Flanagan, L.
    Quinn, C.
    Corkery, B.
    McDermott, E. W.
    Evoy, D.
    Pierce, A.
    O'Donovan, N.
    Crown, J.
    Duffy, M. J.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2234 - 2240
  • [4] Targeting lactate metabolism as a novel therapeutic target in platinum-resistant triple negative breast cancer (TNBC)
    Harada, Narumi
    Varghese, Vidhya
    Xie, Lingmin
    Kenny, Laura M.
    CANCER RESEARCH, 2015, 75
  • [5] Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
    Koni, Malvina
    Castellano, Isabella
    Venturelli, Emilio
    Sarcinella, Alessandro
    Lopatina, Tatiana
    Grange, Cristina
    Cedrino, Massimo
    Femmino, Saveria
    Cossu-Rocca, Paolo
    Orru, Sandra
    D'Ascenzo, Fabrizio
    Cotellessa, Ilaria
    Tampieri, Cristian
    Debernardi, Carla
    Cugliari, Giovanni
    Matullo, Giuseppe
    Camussi, Giovanni
    De Miglio, Maria Rosaria
    Brizzi, Maria Felice
    CANCERS, 2022, 14 (16)
  • [6] Epidermal growth factor receptor (EGFR) and Src as therapeutic targets in triple negative breast cancer (TNBC)
    Canonici, A.
    Browne, A.
    Ibrahim, M.
    Fanning, K.
    Roche, S.
    Conlon, N.
    O'neill, F.
    Meiller, J.
    Cemona, M.
    Morgan, C.
    Hennessy, B.
    Solca, F.
    Crown, J.
    O'donovan, N.
    Eustace, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E133 - E133
  • [7] Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
    Canonici, Alexandra
    Browne, Alacoque L.
    Ibrahim, Mohamed F. K.
    Fanning, Kevin P.
    Roche, Sandra
    Conlon, Neil T.
    O'Neill, Fiona
    Meiller, Justine
    Cremona, Mattia
    Morgan, Clare
    Hennessy, Bryan T.
    Eustace, Alex J.
    Solca, Flavio
    O'Donovan, Norma
    Crown, John
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [8] Evaluation of GABRP as a novel therapeutic target in triple negative breast cancer
    Wali, Vikram B.
    Patwardhan, Gauri A.
    Hatzis, Christos
    Pusztai, Lajos
    CANCER RESEARCH, 2017, 77
  • [9] ADAM17: A Novel Therapeutic Target for Treatment of Triple Negative Breast Cancer.
    McGowan, P. M.
    Mullooly, M.
    Sukor, S.
    Madden, S.
    McDermott, E.
    Pierce, A.
    Crown, J.
    O'Donovan, N.
    Duffy, M. J.
    CANCER RESEARCH, 2011, 71
  • [10] THE ROLE OF IMMUNOTHERAPY IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Rugo, Hope S.
    BREAST, 2017, 36 : S29 - S30
12345